LIPOCINE INC NEW - COM (LPCN) Institutional Ownership

CUSIP: 53630X104

13F Institutional Holders and Ownership History from Q2 2014 to Q2 2023

Type / Class
Equity / COM
Symbol
LPCN on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 53630X104?
CUSIP 53630X104 identifies LPCN - LIPOCINE INC NEW - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of LIPOCINE INC NEW - COM (LPCN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q2 0 $0 -$3,159,666 0
2023 Q1 9,942,227 $3,163,666 -$172,808 $0.32 43
2022 Q4 10,526,835 $4,155,247 -$103,140 $0.40 47
2022 Q3 10,774,300 $4,847,000 -$725,969 $0.45 38
2022 Q2 11,903,096 $9,535,000 -$551,236 $0.80 42
2022 Q1 11,793,973 $16,154,000 +$1,806,198 $1.37 39
2021 Q4 10,612,035 $10,517,000 -$79,775 $0.99 37
2021 Q3 9,180,833 $10,007,000 +$31,285 $1.09 34
2021 Q2 9,120,923 $12,766,000 +$1,221,000 $1.40 27
2021 Q1 8,193,925 $12,370,000 -$291,686 $1.51 37
2020 Q4 8,444,058 $11,467,000 +$1,716,256 $1.36 32
2020 Q3 7,136,635 $10,061,000 +$4,119,257 $1.41 27
2020 Q2 4,301,652 $5,418,000 +$890,259 $1.26 30
2020 Q1 2,844,139 $1,363,000 -$941,790 $0.48 19
2019 Q4 5,496,338 $2,113,000 +$153,089 $0.38 25
2019 Q3 3,162,235 $8,878,011 +$926,397 $2.81 28
2019 Q2 2,852,939 $5,560,008 -$47,002 $1.95 32
2019 Q1 2,869,437 $6,625,009 +$1,543,345 $2.31 30
2018 Q4 2,105,820 $2,724,005 -$802,839 $1.30 23
2018 Q3 2,702,652 $3,730,006 -$207,222 $1.38 29
2018 Q2 2,844,940 $3,699,102 +$945,817 $1.30 29
2018 Q1 2,090,764 $3,196,006 -$6,258,752 $1.53 27
2017 Q4 3,784,866 $13,017,014 -$4,648,572 $3.44 39
2017 Q3 4,673,748 $18,553,016 -$3,170,352 $3.97 37
2017 Q2 5,454,487 $21,925,016 -$7,631,787 $4.02 41
2017 Q1 7,406,801 $28,883,819 +$3,977,362 $3.90 47
2016 Q4 8,229,594 $30,281,636 -$379,932 $3.68 57
2016 Q3 8,234,752 $36,728,602 +$121,233 $4.46 46
2016 Q2 8,620,099 $26,200,971 -$18,301,765 $3.04 53
2016 Q1 9,378,527 $95,200,000 +$1,928,043 $10.15 53
2015 Q4 9,158,845 $118,421,000 -$9,888,160 $12.93 46
2015 Q3 9,214,715 $109,008,000 +$13,510,974 $11.83 44
2015 Q2 8,394,415 $72,022,000 +$35,744,424 $8.58 37
2015 Q1 4,263,824 $29,419,000 +$5,490,521 $6.90 18
2014 Q4 3,504,103 $18,433,000 -$1,511,261 $5.26 20
2014 Q3 3,831,557 $23,408,000 +$1,416,169 $6.11 15
2014 Q2 3,601,511 $21,969,000 +$21,968,989 $6.10 14